Pulmatrix's Grant

Pulmatrix raised a round of funding on , . Investors include National Institutes of Health.

Pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. The platform, called iSPERSE (inhaled small particles easily…

Articles about Pulmatrix's Grant: